glp 1 drugs and ulcerative colitis The alleviating effect mechanism of GLP-1 on Semaglutide and Ulcerative Colitis: Safety
Description
It leads to a delay of gastric emptying, improved glycemic control, and a reduction of feelings of hunger and food craving [21]

Some studies say that as much as half of the weight you lose comes from the loss of lean muscle

While the evidence base for some of these approaches is developing, clinicians play an incredibly important role by providing structured monitoring, reinforcing sustainable lifestyle practices, and tailoring support to individual needs

Injection site reactions, including erythema, pruritus, and nodule formation (particularly with extended-release formulations), occur in approximately 10-20% of patients

In lactating women on tirzepatide, there is no sufficient clinical data that support or argue against its use

Treatment recommendations are individualized and based on safety, appropriateness, and clinical judgment
